Bruce Keyt - 26 Mar 2024 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role: CHIEF SCIENTIFIC OFFICER
Signature: /s/ Misbah Tahir, by power of attorney
Issuer symbol: IGMS
Transactions as of: 26 Mar 2024
Transactions value $: $0
Form type: 4
Filing time: 28 Mar 2024, 19:22:28 UTC
Previous filing: 15 Mar 2024
Next filing: 18 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IGMS	Common Stock	Award	$0	+24K	+13.98%	$0.00	196K	26 Mar 2024	Direct	F1
holding	IGMS	Common Stock						4.04K	26 Mar 2024	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units (RSUs), granted pursuant to the election by the Reporting Person to receive RSUs in lieu of an earned cash bonus for performance in fiscal year 2023. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2024, provided that the Reporting Person remains a service provider through the vesting date.
F2	The securities are held directly by the reporting person's spouse.

Content

These securities are restricted stock units (RSUs), granted pursuant to the election by the Reporting Person to receive RSUs in lieu of an earned cash bonus for performance in fiscal year 2023. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2024, provided that the Reporting Person remains a service provider through the vesting date.

The securities are held directly by the reporting person's spouse.